Genexine: Rights offering (paid-in capital increase) decision
This filing says Genexine has withdrawn its earlier decision to raise money by issuing new shares to a specific third party, combined with a small public offering. It usually means the planned share issuance will not go ahead, so the dilution that would have come from those new shares will not occur under that plan; the filing as given does not state the reason. Genexine filed this on Oct 26, 2026.
High impactPredicted impact: High
Rights offering decision; new shares may be large, and the company's revenue is tiny versus its market value.
Company filing